Five Minutes in Healthcare

Five Minutes in Healthcare - Jim Williams

by Philip F. Jacobus, CEO | September 25, 2024

Jim Williams

Five Minutes in Healthcare is where I discuss current events with some of the industry's most influential leaders.

Today I am joined by Jim Williams, head of the global Molecular Imaging business at Siemens Healthineers, for a discussion about the role of imaging in the new therapeutic drug treatments for Alzheimer’s disease. The conversation is timely, as the FDA recently approved the second major Alzheimer’s therapeutic drug, Eli Lilly's donanemab.

Jim and I previously talked about the rapid adoption of theranostics and where the next treatment breakthroughs might take place. I encourage you to check out that interview after you listen to this one.

We hope you enjoy the conversation. Please tell us what you think, and let us know who you would like to see interviewed next.

View all The Jacobus Report Blog Posts

About Phil Jacobus

Phil Jacobus has been involved in health care since 1977, when he visited China to sell equipment. He has done business in 35 countries and still travels extensively. Phil is active in charity, helps rural clinics and always tries to help DOTmed users when he can.

Phil is a member of AHRA, HFMA, AAMI and the Cryogenic Society of America. He has contributed to a number of magazines and journals and has addressed trade groups.

Phil's proudest achievement is that he has been happily married to his wife Barbara since 1989, who helped him found DOTmed in 1998.



You Must Be Logged In To Post A Comment Sign In If you've already created an account, use your email address and password to sign in using the form below. Login Problems: Click here if you are having login issues. Email address: Password: Forgot your password? Login Problems? View our Legal Notice and Privacy Notice Register Registration is Free and Easy. Enjoy the benefits of The World's Leading New & Used Medical Equipment Marketplace. Register Now!